These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 23525058)
1. Vismodegib: the first drug approved for advanced and metastatic basal cell carcinoma. Dubey AK; Dubey S; Handu SS; Qazi MA J Postgrad Med; 2013; 59(1):48-50. PubMed ID: 23525058 [TBL] [Abstract][Full Text] [Related]
2. Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma. Lyseng-Williamson KA; Keating GM Am J Clin Dermatol; 2013 Feb; 14(1):61-4. PubMed ID: 23329081 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma. Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490 [TBL] [Abstract][Full Text] [Related]
4. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas. Sobanko JF; Okman J; Miller C J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062 [TBL] [Abstract][Full Text] [Related]
5. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma. Proctor AE; Thompson LA; O'Bryant CL Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609 [TBL] [Abstract][Full Text] [Related]
6. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. Cirrone F; Harris CS Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338 [TBL] [Abstract][Full Text] [Related]
7. Vismodegib. Meiss F; Zeiser R Recent Results Cancer Res; 2014; 201():405-17. PubMed ID: 24756807 [TBL] [Abstract][Full Text] [Related]
8. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial. Dessinioti C; Plaka M; Stratigos AJ Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979 [TBL] [Abstract][Full Text] [Related]
9. Vismodegib (Erivedge) for basal cell carcinoma. Med Lett Drugs Ther; 2012 Jul; 54(1394):53-4. PubMed ID: 22777303 [No Abstract] [Full Text] [Related]
10. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib. Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of vismodegib : a new therapeutic agent in the treatment of basal cell carcinoma. Lyons TG; O'Kane GM; Kelly CM Expert Opin Drug Saf; 2014 Aug; 13(8):1125-32. PubMed ID: 25033383 [TBL] [Abstract][Full Text] [Related]